#USA #Princeton #Regulatory Writing #ZYLiQ #version 4.0

ZYLiQ Enhances Automation in Regulatory Writing

Introduction to ZYLiQ Version 4.0
On October 22, 2025, ZYLiQ, a prominent provider of AI and ML-enabled solutions for regulatory medical writing, announced the launch of ZYLiQ Version 4.0. This new release aims to further streamline automation in clinical study reporting (CSR), integrating powerful new modules for regulatory documents. With ZYLiQ being recognized as a pioneer in Generative AI for regulatory text creation, this upgrade boasts a remarkable 75% acceleration in CSR development, illustrating the platform's innovation and effectiveness in overcoming regulatory documentation challenges.

Key Features of Version 4.0
The ZYLiQ Version 4.0 integrates several enhancements into the automation of CSR, including:

• - Automatic Source Type Prediction: The system can now predict the type of sources for user-added sections automatically.
• - Optimized Synopsis Content Creation: This improves the efficiency in generating content that summarizes studies succinctly.
• - Generative AI Textual Adjustments: The upgraded software can now convert verb tenses, introduce concise writing styles, and compile summaries adeptly.
• - AI-Supported Safety and Efficacy Section Drafting: This feature aids authors in preparing critical safety and efficacy sections with ease.

New Modules Debuting in ZYLiQ 4.0
The most exciting aspect of this version is the introduction of new modules catering to various regulatory documents, including:

• - Safety Narratives: ZYLiQ will now automatically pull data from datasets and patient profiles to craft safety descriptions, leading to a reported 90% reduction in completion time.
• - Informed Consent Form (ICF) Generation: This feature captures information from protocols and investigator brochures to guide authors in automatically creating ICFs using sponsor-specific templates.
• - Plain Language Summaries (PLS and PLPS): These tools generate simplified, layman-friendly summaries based on CSR inputs and protocols, making complex documents more accessible.
• - Redaction and Anonymization: ZYLiQ now facilitates the masking or anonymizing of sensitive information across documents to ensure compliance and privacy.

A Unique Opportunity for Customers
To help prospective customers experience the capabilities of this innovative solution, ZYLiQ is offering a complimentary two-week pilot project. This initiative provides a comparative analysis between traditional processes and the accelerated automation provided by ZYLiQ, promising a glimpse into the future of regulatory writing.

Company Insight
Farha Feroze, the inventor of ZYLiQ and Director of Product Management, stated, "Our focus on automating documents that contain regulatory content – as opposed to spreading our efforts across various document types – has allowed us to develop an exceptionally effective solution. We are thrilled to expand beyond CSR with Version 4.0, delivering the same level of innovation to other regulatory documents. I am immensely proud of my team's dedication to advancing technologies and improving application cases."

Conclusion
ZYLiQ leverages three decades of expertise in the Contract Research Organization (CRO) industry with Symbiance to merge deep biopharmaceutical knowledge with proven AI and ML innovations. Understanding client challenges remains at the core of ZYLiQ's offerings.

For more information or to book a demo, visit ZYLiQ's website or contact them at +1 949-878-2121.